Highlights and Quick Summary
- Income from Discontinued Operations for the quarter ending December 31, 2022 was $4.65 Million (a -95.11% decrease compared to previous quarter)
- Year-over-year quarterly Income from Discontinued Operations increased by Infinity%
- Annual Income from Discontinued Operations for 2022 was $108 Million (a 479.87% increase from previous year)
- Annual Income from Discontinued Operations for 2021 was $18.6 Million (a -128.21% decrease from previous year)
- Annual Income from Discontinued Operations for 2020 was $-66.1 Million (a -56.97% decrease from previous year)
- Twelve month Income from Discontinued Operations ending December 31, 2022 was $108 Million (a -1.84% decrease compared to previous quarter)
- Twelve month trailing Income from Discontinued Operations increased by 665.81% year-over-year
Trailing Income from Discontinued Operations for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| $108 Million | $110 Million | $11.7 Million | $14.1 Million |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Income from Discontinued Operations of Precigen, Inc.
Most recent Income from Discontinued Operationsof PGEN including historical data for past 10 years.Interactive Chart of Income from Discontinued Operations of Precigen, Inc.
Precigen, Inc. Income from Discontinued Operations for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $4.65 | $95.02 | $8.42 | $0.0 | $108.09 |
| 2021 | $6.67 | $-3.45 | $10.89 | $4.53 | $18.64 |
| 2020 | $-1.31 | $-1.97 | $-27.65 | $-35.15 | $-66.08 |
| 2019 | $-133.14 | $-4.58 | $-6.63 | $-9.24 | $-153.58 |
| 2018 | – | – | – | – | $-134.22 |
| 2017 | – | – | – | – | $-46.38 |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology